Scholarlink

Objective <p>To analyze the differences in contrast-enhanced ultrasound (CEUS) patterns among synovial pathotypes in rheumatoid arthritis (RA), aiming to provide a non-invasive basis for differentiating RA subtypes.</p> Materials and methods <p>A total of 151 patients with RA (involving 151 joints) were included and underwent gray-scale ultrasound, Power Doppler ultrasound (PDUS), CEUS, and ultrasound-guided synovial biopsy sequentially. The synovial tissues were classified into three pathological types by immunohistochemistry, including lympho-myeloid, diffuse-myeloid, and pauci-immune. This study analyzed the differences in ultrasound features among different synovial pathotypes and proposed five distinct synovial vascular enhancement patterns. Variables with correlations &gt; 0.3 were selected to construct three classification models, namely Model 1 (Clinical variables), Model 2 (Clinical-PDUS), and Model 3 (Clinical-PDUS-CEUS).</p> Results <p>CEUS synovial vascular enhancement patterns: the pauci-immune predominantly exhibited pattern II (35.7%), the diffuse-myeloid predominantly exhibited pattern IV (42.5%), and the lympho-myeloid predominantly exhibited pattern V (72.0%). Qualitative parameters (enhancement pattern, degree, and range) and quantitative parameters (peak intensity [PI], maximum gradient [MGrad], and wash-out area under the curve [WoAUC]) of CEUS were significantly associated with pathological types (<i>r</i> = 0.426–0.602, all <i>p</i> &lt; 0.001). In differentiating pathological subtypes, Model 3 achieved an AUC of 0.902, which was significantly higher than Model 1 (AUC = 0.728) and Model 2 (AUC = 0.751). However, the diagnostic efficacy for the diffuse-myeloid still needs optimization (AUC = 0.818).</p> Conclusions <p>CEUS features of synovium can help differentiate RA synovial pathotypes and may provide important guidance for the early diagnosis and treatment selection of RA.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>Are there differences between RA synovial pathotype and their corresponding contrast-enhanced (CEUS) findings?</i></p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>Five patterns of synovial vascular enhancement corresponding to pathology types were identified, and a model was constructed</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>CEUS synovial qualitative analysis and quantitative parameters can help differentiate RA synovial pathotypes</i>.</p> Graphical Abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The value of contrast-enhanced ultrasound in synovial pathotypes of rheumatoid arthritis: an exploratory study

  • 期刊论文

  • 发表日期：

    2025年8月20日

查看全文
  • Ting Wang,
  • Zhen Wang,
  • Yakun Yu,
  • Lele Huang,
  • Yuan Wang,
  • Yan Li,
  • Xuejiao Shen,
  • Jiaqi Wei,
  • Yangyang Zhu,
  • Yingying Jia,
  • Ci Yin,
  • Fang Nie

摘要

Objective

To analyze the differences in contrast-enhanced ultrasound (CEUS) patterns among synovial pathotypes in rheumatoid arthritis (RA), aiming to provide a non-invasive basis for differentiating RA subtypes.

Materials and methods

A total of 151 patients with RA (involving 151 joints) were included and underwent gray-scale ultrasound, Power Doppler ultrasound (PDUS), CEUS, and ultrasound-guided synovial biopsy sequentially. The synovial tissues were classified into three pathological types by immunohistochemistry, including lympho-myeloid, diffuse-myeloid, and pauci-immune. This study analyzed the differences in ultrasound features among different synovial pathotypes and proposed five distinct synovial vascular enhancement patterns. Variables with correlations > 0.3 were selected to construct three classification models, namely Model 1 (Clinical variables), Model 2 (Clinical-PDUS), and Model 3 (Clinical-PDUS-CEUS).

Results

CEUS synovial vascular enhancement patterns: the pauci-immune predominantly exhibited pattern II (35.7%), the diffuse-myeloid predominantly exhibited pattern IV (42.5%), and the lympho-myeloid predominantly exhibited pattern V (72.0%). Qualitative parameters (enhancement pattern, degree, and range) and quantitative parameters (peak intensity [PI], maximum gradient [MGrad], and wash-out area under the curve [WoAUC]) of CEUS were significantly associated with pathological types (r = 0.426–0.602, all p < 0.001). In differentiating pathological subtypes, Model 3 achieved an AUC of 0.902, which was significantly higher than Model 1 (AUC = 0.728) and Model 2 (AUC = 0.751). However, the diagnostic efficacy for the diffuse-myeloid still needs optimization (AUC = 0.818).

Conclusions

CEUS features of synovium can help differentiate RA synovial pathotypes and may provide important guidance for the early diagnosis and treatment selection of RA.

Key Points

Question Are there differences between RA synovial pathotype and their corresponding contrast-enhanced (CEUS) findings?

Findings Five patterns of synovial vascular enhancement corresponding to pathology types were identified, and a model was constructed.

Clinical relevance CEUS synovial qualitative analysis and quantitative parameters can help differentiate RA synovial pathotypes.

Graphical Abstract